First clinical experience with belzutifan in von Hippel–Lindau disease associated CNS hemangioblastoma

por Dhawan, Andrew, Peereboom, David M, Stevens, Glen HJ
Publicado 2022

Infected host responses across entomopathogenic nematode phylogeny

por Erdogan, Hilal, Stevens, Glen, Stevens, Asa, Shapiro-Ilan, David, Kaplan, Fatma, Alborn, Hans, Lewis, Edwin
Publicado 2021

Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature

por Abu-Gheida, Ibrahim, Chao, Samuel, Murphy, Erin, Suh, John, Stevens, Glen H., Mohammadi, Alireza M., McNamara, Michael, Yu, Jennifer S.
Publicado 2019

TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES

por Murphy, Erin, Yang, Kailin, Suh, John, Yu, Jennifer, Schilero, Cathy, Mohammadi, Alireza, Stevens, Glen, Angelov, Lilyana, Vogelbaum, Michael, Barnett, Gene, Ahluwalia, Manmeet, Neyman, Gennady, Chao, Samuel
Publicado 2019

Conspecific and heterospecific pheromones stimulate dispersal of entomopathogenic nematodes during quiescence

por Kaplan, Fatma, Perret-Gentil, Abigail, Giurintano, Julie, Stevens, Glen, Erdogan, Hilal, Schiller, Karl C., Mirti, Amaleah, Sampson, Edith, Torres, Cedric, Sun, Jiayi, Lewis, Edwin E., Shapiro-Ilan, David
Publicado 2020

THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS

por Sagar, Soumya, Lauko, Adam, Barnett, Addison, Wei, Wei, Chao, Samuel, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Publicado 2019

THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS

por Barnett, Addison, Sagar, Soumya, Lauko, Adam, Wei, Wei, Chao, Samuel, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Publicado 2019

THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES

por Lauko, Adam, Sagar, Soumya, Barnett, Addison, Wei, Wei, Chao, Samuel, Stevens, Glen, Peereboom, David, Yu, Jennifer, Murphy, Erin, Angelov, Lilyana, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Publicado 2019

THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES

por Lauko, Adam, Ali, Assad, Sagar, Soumya, Barnett, Addison, Li, Hong, Chao, Samuel, Pennell, Nathan, Stevens, Glen, Peereboom, David, Yu, Jennifer, Murphy, Erin, Angelov, Lilyana, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Publicado 2019

THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS

por Barnett, Addison, Lauko, Adam, Ali, Assad, Li, Hong, Sagar, Soumya, Chao, Samuel, Pennell, Nathan, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Publicado 2019

THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM)

por Lauko, Adam, Thapa, Bicky, Muhsen, Baha’eddin, Borghei-Razavi, Hamid, Wei, Wei, Chao, Samuel, Stevens, Glen, Peereboom, David, Yu, Jennifer, Murphy, Erin, Angelov, Lilyana, Mohammadi, Alireza, Suh, John, Barnett, Gene, Pennell, Nathan, Ahluwalia, Manmeet
Publicado 2019